Your browser doesn't support javascript.
loading
Alveolar macrophages in early stage COPD show functional deviations with properties of impaired immune activation.
Baßler, Kevin; Fujii, Wataru; Kapellos, Theodore S; Dudkin, Erika; Reusch, Nico; Horne, Ari; Reiz, Benedikt; Luecken, Malte D; Osei-Sarpong, Collins; Warnat-Herresthal, Stefanie; Bonaguro, Lorenzo; Schulte-Schrepping, Jonas; Wagner, Allon; Günther, Patrick; Pizarro, Carmen; Schreiber, Tina; Knoll, Rainer; Holsten, Lisa; Kröger, Charlotte; De Domenico, Elena; Becker, Matthias; Händler, Kristian; Wohnhaas, Christian T; Baumgartner, Florian; Köhler, Meike; Theis, Heidi; Kraut, Michael; Wadsworth, Marc H; Hughes, Travis K; Ferreira, Humberto J; Hinkley, Emily; Kaltheuner, Ines H; Geyer, Matthias; Thiele, Christoph; Shalek, Alex K; Feißt, Andreas; Thomas, Daniel; Dickten, Henning; Beyer, Marc; Baum, Patrick; Yosef, Nir; Aschenbrenner, Anna C; Ulas, Thomas; Hasenauer, Jan; Theis, Fabian J; Skowasch, Dirk; Schultze, Joachim L.
Afiliación
  • Baßler K; Genomics and Immunoregulation, Life & Medical Sciences (LIMES) Institute, University of Bonn, Bonn, Germany.
  • Fujii W; Genomics and Immunoregulation, Life & Medical Sciences (LIMES) Institute, University of Bonn, Bonn, Germany.
  • Kapellos TS; Genomics and Immunoregulation, Life & Medical Sciences (LIMES) Institute, University of Bonn, Bonn, Germany.
  • Dudkin E; Computational Life Sciences, Life & Medical Sciences (LIMES) Institute, University of Bonn, Neuherberg, Germany.
  • Reusch N; Genomics and Immunoregulation, Life & Medical Sciences (LIMES) Institute, University of Bonn, Bonn, Germany.
  • Horne A; Genomics and Immunoregulation, Life & Medical Sciences (LIMES) Institute, University of Bonn, Bonn, Germany.
  • Reiz B; Comma Soft AG, Bonn, Germany.
  • Luecken MD; Helmholtz Zentrum München - German Research Center for Environmental Health, Institute of Computational Biology, Neuherberg, Germany.
  • Osei-Sarpong C; Immunogenomics & Neurodegeneration, German Center for Neurodegenerative Diseases and the University of Bonn, Bonn, Germany.
  • Warnat-Herresthal S; Genomics and Immunoregulation, Life & Medical Sciences (LIMES) Institute, University of Bonn, Bonn, Germany.
  • Bonaguro L; Genomics and Immunoregulation, Life & Medical Sciences (LIMES) Institute, University of Bonn, Bonn, Germany.
  • Schulte-Schrepping J; PRECISE Platform for Single Cell Genomics and Epigenomics, German Center for Neurodegenerative Diseases (DZNE) and the University of Bonn, Bonn, Germany.
  • Wagner A; Systems Medicine, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
  • Günther P; Genomics and Immunoregulation, Life & Medical Sciences (LIMES) Institute, University of Bonn, Bonn, Germany.
  • Pizarro C; Department of electrical engineering and computer science, University of California, Berkeley, CA, United States.
  • Schreiber T; Center for computational biology, University of California, Berkeley, CA, United States.
  • Knoll R; PRECISE Platform for Single Cell Genomics and Epigenomics, German Center for Neurodegenerative Diseases (DZNE) and the University of Bonn, Bonn, Germany.
  • Holsten L; Department of Internal Medicine II, University Hospital Bonn, Section of Pneumology, Bonn, Germany.
  • Kröger C; Department of Internal Medicine II, University Hospital Bonn, Section of Pneumology, Bonn, Germany.
  • De Domenico E; Genomics and Immunoregulation, Life & Medical Sciences (LIMES) Institute, University of Bonn, Bonn, Germany.
  • Becker M; PRECISE Platform for Single Cell Genomics and Epigenomics, German Center for Neurodegenerative Diseases (DZNE) and the University of Bonn, Bonn, Germany.
  • Händler K; Prevention, Aging & Systems Immunology, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Bonn, Germany.
  • Wohnhaas CT; Genomics and Immunoregulation, Life & Medical Sciences (LIMES) Institute, University of Bonn, Bonn, Germany.
  • Baumgartner F; Genomics and Immunoregulation, Life & Medical Sciences (LIMES) Institute, University of Bonn, Bonn, Germany.
  • Köhler M; Prevention, Aging & Systems Immunology, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Bonn, Germany.
  • Theis H; PRECISE Platform for Single Cell Genomics and Epigenomics, German Center for Neurodegenerative Diseases (DZNE) and the University of Bonn, Bonn, Germany.
  • Kraut M; Systems Medicine, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
  • Wadsworth MH; PRECISE Platform for Single Cell Genomics and Epigenomics, German Center for Neurodegenerative Diseases (DZNE) and the University of Bonn, Bonn, Germany.
  • Hughes TK; Systems Medicine, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
  • Ferreira HJ; PRECISE Platform for Single Cell Genomics and Epigenomics, German Center for Neurodegenerative Diseases (DZNE) and the University of Bonn, Bonn, Germany.
  • Hinkley E; Systems Medicine, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
  • Kaltheuner IH; Computational Biology, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany.
  • Geyer M; Comma Soft AG, Bonn, Germany.
  • Thiele C; Comma Soft AG, Bonn, Germany.
  • Shalek AK; PRECISE Platform for Single Cell Genomics and Epigenomics, German Center for Neurodegenerative Diseases (DZNE) and the University of Bonn, Bonn, Germany.
  • Feißt A; Systems Medicine, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
  • Thomas D; PRECISE Platform for Single Cell Genomics and Epigenomics, German Center for Neurodegenerative Diseases (DZNE) and the University of Bonn, Bonn, Germany.
  • Dickten H; Systems Medicine, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
  • Beyer M; Institute for Medical Engineering & Science, Department of Chemistry, and Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, United States.
  • Baum P; Broad Institute of MIT and Harvard; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, United States.
  • Yosef N; Institute of Structural Biology, University Hospital, University of Bonn, Bonn, Germany.
  • Aschenbrenner AC; PRECISE Platform for Single Cell Genomics and Epigenomics, German Center for Neurodegenerative Diseases (DZNE) and the University of Bonn, Bonn, Germany.
  • Ulas T; PRECISE Platform for Single Cell Genomics and Epigenomics, German Center for Neurodegenerative Diseases (DZNE) and the University of Bonn, Bonn, Germany.
  • Hasenauer J; Systems Medicine, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
  • Theis FJ; Institute of Structural Biology, University Hospital, University of Bonn, Bonn, Germany.
  • Skowasch D; Biochemistry & Cell Biology of Lipids, Life & Medical Sciences (LIMES) Institute, University of Bonn, Bonn, Germany.
  • Schultze JL; University Clinics for Radiology, University Hospital Bonn, Bonn, Germany.
Front Immunol ; 13: 917232, 2022.
Article en En | MEDLINE | ID: mdl-35979364
Despite its high prevalence, the cellular and molecular mechanisms of chronic obstructive pulmonary disease (COPD) are far from being understood. Here, we determine disease-related changes in cellular and molecular compositions within the alveolar space and peripheral blood of a cohort of COPD patients and controls. Myeloid cells were the largest cellular compartment in the alveolar space with invading monocytes and proliferating macrophages elevated in COPD. Modeling cell-to-cell communication, signaling pathway usage, and transcription factor binding predicts TGF-ß1 to be a major upstream regulator of transcriptional changes in alveolar macrophages of COPD patients. Functionally, macrophages in COPD showed reduced antigen presentation capacity, accumulation of cholesteryl ester, reduced cellular chemotaxis, and mitochondrial dysfunction, reminiscent of impaired immune activation.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Macrófagos Alveolares / Enfermedad Pulmonar Obstructiva Crónica Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Front Immunol Año: 2022 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Macrófagos Alveolares / Enfermedad Pulmonar Obstructiva Crónica Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Front Immunol Año: 2022 Tipo del documento: Article País de afiliación: Alemania